ADVANCED RESPIRATORY TECHNOLOGIES, INC. — Department of Defense SBIR Phase II: DEFENSE HEALTH AGENCY PHASE II SBIR FOR PROJECT CONTINUED DEVELOPMENT OF THE COAXIAL FEMOR
ADVANCED RESPIRATORY TECHNOLOGIES, INC. — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,976 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Advanced Respiratory Technologies received nearly $1.3 million from the Defense Health Agency to continue developing a coaxial femoral cannula for extracorporeal life support. The device aims to enable rapid initiation of life support in forward battlefield conditions, during extended care, and while transporting patients.
- Amount
- $1,299,976
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- PA
- Period
- 2024-09-09 → 2027-01-08
Technology domains
Description
DEFENSE HEALTH AGENCY PHASE II SBIR FOR PROJECT CONTINUED DEVELOPMENT OF THE COAXIAL FEMORAL CANNULA (CFC) FOR FAR FORWARD EXTRACOPOREAL LIFE SUPPORT INITIATION, PROLONGED FIELD CARE, AND TRANSPORT